period (132,736) (121,587) -9% (113,896) -17% Margin -19% -14% -13% Portion of the Companies’ shareholders (60,913) (49,476) -23% (39,057) -56% Margin -9% -5% -4% Financial performance in Q2/2017 Revenues
Baht, decreased 0.45 million Baht or 1.04% from the same period last year due to the Company repay a portion of loan principal to financial institutions according to debt restructuring agreement dated
investors**. The investment portion of the distressed bond fund would consist of distressed bonds accounting for at least 60 percent of the total net asset value (NAV), while the rest may invest in other
determination. 7. Where not all of the debt securities being offered are guaranteed, provide a statement for a non-guaranteed portion. B. Covenants Relating to the Issuance of the Debt Securities 1 “senior
Baht 1,810 million last year mainly due to waiver of interest of Baht 5,506 from creditors consequent to conversion of the Debt to Equity, Gain from capital reduction in Subsidiary Baht 1,130 million and
1,848per ton in 2017. Management’s Discussion and Analysis (MD&A) for year 2017 2 As the result of EGM holding on 30 August 2017, the shareholders voted down the Debt Equity conversion. On 13 November 2017
cash margin by Baht 1,848per ton in 2017. Management’s Discussion and Analysis (MD&A) for year 2017 (Revised) 2 As the result of EGM holding on 30 August 2017, the shareholders voted down the Debt Equity
service agreement between Solvay and AGC, plus higher transportation costs from export sales portion. 3. In Q2 2017, the Company and its subsidiaries recorded additional impairment loss from the liquidation
greater export sales portion. 3. In Q3 2017, the Company and its subsidiaries recorded the assets’ impairment loss and write- off of Solvay Biochemicals (Taixing) Limited (“SBT”) net amounting to 132 MB
cash and cash equivalent at 40.25 million baht, up by 19.05 million baht. This was in line with the lower volume of trade receivables due to better quality of trade receivables in terms of debt payment